Breast Cancer
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Commentary
Starting Mammography at Age 40 May Backfire Due to False Positives
A patient who follows the USPSTF recommendation and starts screening at age 40 has a 42% chance of having at least...
From the Journals
Is Minimal Access Nipple-Sparing Mastectomy a Safer Option?
Researchers performed a retrospective study of 1,583 patients with breast cancer who underwent conventional nipple-sparing mastectomy or minimal...
From the Journals
Should Genetic Testing Be Routine for Breast Cancer?
Researchers conducted a cross-sectional study of 729 women with newly diagnosed invasive breast cancer to assess the efficacy of universal genetic...
Conference Coverage
A Simple Blood Test May Predict Cancer Risk in T2D
Can the markers of inflammation IL-6, tumor necrosis factor alpha (TNF-alpha), and high-sensitivity C-reactive protein (hsCRP) be predictive...
Feature
Should All Patients With Early Breast Cancer Receive Adjuvant Radiotherapy?
Researchers analyzed data from 589 patients with early breast cancer who were randomized to receive either high-dose or no radiotherapy.
From the Journals
High Breast Cancer Risk With Menopausal Hormone Therapy & Strong Family History
A modeling study integrated a data set of women with age-specific breast cancer risk with family history and another that covers relative risk for...
From the Journals
Breast Cancer Hormone Therapy May Protect Against Dementia
Researchers identified more than 18,000 women with breast cancer who did and did not receive hormone-modulating therapy within 3 years of their...
From the Journals
False-Positive Mammography Results Linked to Reduced Rates of Future Screenings
Researchers analyzed more than three million screening mammograms from more than 1 million women.
Feature
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Researchers analyzed whole genome sequencing data from 10,866 women in the WHI to explore possible associations between CHIP, mCA, and solid...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.